Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Jury finds Teva fueled opioid addiction in New York - YouTube
Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
Biden Admin Urges Supreme Court to Hear 'Skinny Labels' Case Between Teva, GSK
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Teva Pharm to lay off a quarter of workforce, suspends dividend By Reuters
Israel's Teva agrees to pay $126 mln to US hospitals over opioids
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters
Mylan's Chairman was Right | Ctech
/cloudfront-us-east-2.images.arcpublishing.com/reuters/NTZR6T726RLT7GRNRNBROU2NCQ.jpg "US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters")
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters
GSK's $235 million verdict revived against Teva, again | Reuters
What's 'down' with Teva? - Israel News - The Jerusalem Post
AstraZeneca slumps on report CEO is heading to Teva – New York Daily News
Fears of Israeli job cuts at Teva sparks call for general strike | Reuters
Teva profit plummets, stock slides | Ctech
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Sanofi buys into Teva's anti-TL1A therapy for IBD | pharmaphorum
Teva Pharmaceutical Industries – The Forward
Teva drops migraine-drug patent case against Eli Lilly | Nasdaq
Teva Pharmaceutical Set for Major Layoffs in Israel, U.S.: Report
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
InnovationRx: Israel Makes Up 8% Of Teva's Global Production
Teva divesting $1 billion in assets to clear Allergan deal
Teva delays 33% of Jerusalem layoffs until 2019 - Israel News - The Jerusalem Post
Teva to pay $523m. to New York as it looks to move past opioid lawsuits - The Jerusalem Post
Why Europe's Drug Shortages May Get Worse
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PTTVJLJBQNLRBHDEX576PT7LII.jpg "Teva expects to start paying U.S. opioid settlement in 2023 | Reuters")
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
